Eli Lilly and Company

06/05/2022 | Press release | Distributed by Public on 06/05/2022 14:39

Jardiance® decreased relative risk of hospitalization for heart failure by 50% versus DPP-4 inhibitors and by 30% versus GLP-1 receptor agonists in adults with type 2 diabetes[...]